EN
HI
Summary
As of 15 Sep, 2026, Alkem Laboratories stock price is ₹5087.5. During the trading session, the stock has moved between an intraday low of ₹5051.00 and an intraday high of ₹5128.00. Over the last 52 weeks, Alkem Laboratories has traded between ₹5051.00 and ₹5933.50.
The stock has recorded a trading volume of 2,38,760 shares,. Its Average Traded Price (ATP) is ₹5083.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 23 @ ₹5087.50.
Alkem Laboratories has an upper circuit limit of ₹5596.00 and a lower circuit limit of ₹4579.00. The total value traded stands at ₹121.38 CR, and the delivery percentage for the day is 78.42%.
The stock is currently traded with a market lot size of 1. Alkem Laboratories also offers a dividend yield of 1.04%.
Alkem Laboratories Share Price Chart
Alkem Laboratories Share Key Metrics
Volume
2.39 L
Market Cap
60828.69 CR
LTQ@LTP
23@5087.50
ATP
5083.69
Var Margin
12.5 %
Circuit Range
4579-5596
Delivery %
78.42 %
Value
121.38 CR
ASM/GSM
No
Market Lot
1
Alkem Laboratories Fundamentals
P/E Ratio
28.21
P/B Ratio
4.25
Div. Yield
1.04
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Alkem Laboratories Resistance and Support
Pivot 5088.83
Resistance
First Resistance
5126.66
Second Resistance
5165.83
Third Resistance
5203.66
Support
First Support
5049.66
Second Support
5011.83
Third Support
4972.66
Alkem Laboratories Futures & Options
Alkem Laboratories Option Chain
View Price, OI, Greeks & More...
29SEP26
5136.50
18.00 (0.35%)
27OCT26
5155.50
11.00 (0.21%)
23NOV26
5167.50
0.00 (0.00%)
ALKEM|29SEP26 CE 5050.00
0.00
-698.2 (-100%)
ALKEM|29SEP26 PE 5100.00
66.85
-6.25 (-8.55%)
Alkem Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 5122 | 5087.5 | -0.98% | 5128 | 5051 |
| Thu Sep 10 2026 | 5166 | 5138 | -0.02% | 5185 | 5104.5 |
| Wed Sep 09 2026 | 5181 | 5139 | -0.81% | 5222 | 5139 |
Alkem Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results & Interim Dividend |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results & Interim Dividend |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Alkem Laboratories News
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alkem Laboratories announced the launch of Renocia Exo™, India's first patented Ginsenoside Exosome-based hair growth serum. This new generation therapy strengthens the company's dermatology portfolio by offering a multi-targeted approach to hair loss management.
Sep 08 2026 15:09:17
Alkem Laboratories Ltd - 539523 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
HDFC Mutual Fund schemes' aggregate holding in Alkem Laboratories crossed 5% to reach 5.017% as of August 24, 2026. This substantial acquisition of 0.021% triggers a mandatory disclosure under SAST regulations.
Aug 26 2026 17:23:41
Read More
Alkem Laboratories Management
| Name | Position |
|---|---|
| Neela Bhattacherjee | Non Executive Independent Director |
| Manish Narang | President – Legal, Company Secretary & Compliance Officer |
Alkem Laboratories Similar Stocks
Mankind Pharma Ltd.
2280.00
0.00 (0.00%)
Glenmark Pharmaceuticals Ltd.
2419.20
0.00 (0.00%)
Fortis Healthcare Ltd.
887.80
0.00 (0.00%)
Aster DM Quality Care Ltd.
763.05
0.00 (0.00%)
Biocon Ltd.
390.65
0.00 (0.00%)
Abbott India Ltd.
25550.00
0.00 (0.00%)
Anthem Biosciences Ltd.
940.90
0.00 (0.00%)
Ipca Laboratories Ltd.
1968.50
0.00 (0.00%)
Gland Pharma Ltd.
2922.30
0.00 (0.00%)
Glaxosmithkline Pharmaceuticals Ltd.
2828.40
0.00 (0.00%)
Alkem Laboratories FAQs
The Buying Price of Alkem Laboratories share is 5087.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alkem Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alkem Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alkem Laboratories shares is 28.21. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alkem Laboratories shares is 4.25. Useful to assess the stock's value relative to its book value.
To assess Alkem Laboratories’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alkem Laboratories is 60828.69 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alkem Laboratories share price is 5933.50 & 5051.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alkem Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ALKEM
